In contrast to NPC and LELC, EBVaGCs exhibit Type I latency, with the expression of BARTs, low levels of EBNA1, and lack of EBNA2 and LMP1 (68). This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.